Eli Lilly’s Mounjaro KwikPen

India approves Eli Lilly’s Mounjaro KwikPen for diabetes and obesity, offering a novel dual-action therapy

India approves Eli Lilly’s Mounjaro KwikPen for diabetes and obesity, offering a novel dual-action therapy

Kavita Bajeli-Datt

26 Jun 2025

2 min read

The New Indian Express

www.newindianexpress.com